| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_985bec8c1d2bba3c8e397f6f68b5359d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35260bc30bbe7a54016015dae8770da4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0daf58543af0098729859d80de7ae9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aceb06e8129b68340f88ea9931b42c4 |
| publicationDate |
2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3351262-A1 |
| titleOfInvention |
Curaglutide for in treatment of prediabetes, diabetes, obesity and metabolic diseases associated thereto |
| abstract |
The present invention relates to curaglutide, which is a proteolysis resistant GLP-1 analogue, for use in prophylaxis and/or treatment of pre-diabetes, diabetes, obesity and metabolic diseases associated thereto. |
| priorityDate |
2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |